Buffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

• The small molecules segment is likely to capture the maximum share (~75%) due to the extensive therapeutic potential of small molecules and the rising occurrence of chronic illnesses

  80% confidence

• More than 70 companies are offering buffer manufacturing services for different packaging formats; close to 55% of the buffer manufacturing service providers are based in North America

  80% confidence

• The liquid formulations segment is likely to capture the maximum share (~70%) due to liquid buffers providing consistency between batches and minimizing the chance of human mistakes

  80% confidence

• North America is likely to capture the majority share (~40%) in the overall market currently, and this trend is unlikely to change in the future

  80% confidence

• The reusable buffer mixing / preparation equipment market segment is likely to capture the majority share (~80%) in the overall market in the current year and is likely to grow at a relatively faster rate during the forecast period

  80% confidence

• The commercial scale segment is likely to capture the maximum share (~85%) and this trend is likely to remain the same in the coming years

  80% confidence

• The buffer preparation market size is currently valued at USD 8.58 billion and is projected to reach 17.96 billion by 2035, growing at a CAGR of 7.8% during the forecast period

  80% confidence

• Around 60 buffer manufacturing systems are currently available in the market for stabilizing drug components in biopharmaceuticals; notably, most of these buffer systems are offered by players based in the US

  80% confidence

• The market in Asia-Pacific is likely to grow at a high CAGR (8%), during the forecast period

  80% confidence

• Close to 20% of the total partnership deals have been signed in the last two years, showing growing stakeholder interest in buffer manufacturing

  80% confidence

• The antibodies segment is likely to capture the maximum share (~55%) of the overall market

  80% confidence

• The bottles segment captures the majority share (~40%) in the overall market in the current year and is likely to dominate the market in the future

  80% confidence

• 86% of the buffer manufacturing systems are fabricated using stainless steel; 95% of the buffer systems work automatically with various controls for pH, conductivity, temperature and pressure

  80% confidence

• Over 60% of the firms engaged in this domain manufacture custom buffers; most of these buffers have been formulated as liquid bottles

  80% confidence

• The cell and gene therapies segment will grow at a significantly higher CAGR (19.5%) throughout the forecast period

  80% confidence